- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 4.51M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 4.3M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 607.21K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.11M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.11M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $6.18M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $8.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $137.69K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$211.89K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.79M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.49M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $10.07M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.49M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.07M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.51 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.65 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.51 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.65 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $645.47K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $341.54K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.2M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.22M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.26M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.03M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $4M |